Antipsychotic drugs Flashcards

1
Q

characteristics of typicals

A

older
more extrapyramidal side effects
treat positive symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

effects of typicals

A

induce state of apathy, lack of initiation, limited range of emotion
reduce confusion and agitation in psychotic patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

characteristics of atypicals

A

newer
less extrapyramidal side effects
first line for out patient
treat positive and negative symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

major receptor target for typicals

A

D2 dopamine receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

off target receptors for typicals and their effects

A

alpha and muscarinic- anticholinergic side effects
H1- weight gain, sedation
serotonin 2c- weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what makes one atypical

A

5HT2a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

relationship between receptor and dose

A

higher D2 affinity= lower dose recquried

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

nigrostriatal pathway

A

substantia nigra to basal ganglia
movement
hyperactive in schizophrenia
degeneration in parkinson’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

mesolimbic pathway

A

VTA to nucleus accumbent

hyperactive in schizophrenia- positive symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

mesocortical pathway

A

tegmental area to cortex

hypoactive in schizophrenia- negative symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

tubuloinfundibular pathwya

A

tegmental area to hypothalamus

controls prolactin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

typical antipsychotics

A
haloperidol
trifluoperazine
fluphenazine
thioridazine
chlorpromazine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

high affinity for D2 typical

A

trifluoperazine
fluphenazine
haloperidol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

low affinity for D2 typical

A

thioridazine

chlorpromazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

atypicals

A
aripiprazole
clozapine
olanzapine
quetiapine
risperadone
ziprasidone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

clinical indications for typicals

A
schizophrenia- positive symptoms
acute mania- temporarily for slow onset of Li
psychosis
tourette's syndrome
parities
intractable hiccups
nausea and vomiting
movement disorders
17
Q

treatment concerns with typicals

A

non adherance- cause of relapse
inadequate dosing- treatment failure
look for organic cause if no improvement

18
Q

major effects of high potency typicals

A

can’t pee can’t see can’t spit can’t poop

EPS

19
Q

EPS of high potency typicals

A

acute dystonia
parkinsonism
akathisia
tardive dyskinesia

20
Q

acute dystonia

A

4 h onset

spasm of head/neck/face muscles

21
Q

parkinsonism

A

days/weeks onset

muscle rigidity, bradykinesia, tremor, shuffling gait

22
Q

akthisia

A

days/weeks onset

urge to move

23
Q

treatment of acute dystonia, parkinsonism, akthisia

A

benztropine
trihexyphenidyl
diphenydramine

24
Q

treatment for tardive dyskinesia

A

switch to lower dose or an atypical

25
Q

tardive dyskinesisa

A

4 month onset
involuntary repetitive men tents of face/neck
worse with directed movement
irreversible

26
Q

major side effect low potency typical

A

increased non specific effects
sedation- histamin antagonist
orthostatic hypotension, sexual dysfunction- alpha
dry mouth, constipation, vision problems- muscarinic

27
Q

specific ADR with chlorpromazine

A

corneal deposits

28
Q

specify ADR with thirodazine

A

retinitis pigments

retrograde ejaculation

29
Q

side effects of all typicals

A

hyperprolactinemia

neuroleptic malignant syndrome

30
Q

neuroleptic malignant syndrome

A
stiff
hot
altered consciousness
elevated CK
autonomic instability
31
Q

treatment of neuroleptic malignant syndrome

A

dantrolene
bromocriptine
amatadine
benzodiazepines